41 / 64
85
Contenido disponible en
www.neumologia-pediatrica.cl15. Bradley JS, Byington CL, Shah SS, et al. Executive Summary: The
management of community acquired pneumonia in infants and
children older than 3 months of age: Clinical practice guidelines by
the Pediatric Infectious Disease Society and the Infectious Disease
Society of America. Clin Infect Dis 2011; 53: 617-30.
16. Agudelo B, Arango M, Cala L, Manotas M, Vásquez C, Agudelo
BI, et al. Guía de práctica clínica en el tratamiento del niño con
neumonía adquirida en la comunidad. Asociación Colombiana de
Neumología Pediátrica Guías de práctica clínica 2010 Guía No. 5
http://issuu.com/acnp/docs/neumonia1?e=3790791/2606451.
17. Barnes NP, Hull J, Thomson AH. Medical management of
parapneumonic pleural disease. Pediatr Pulmonol 2005; 39: 127-
34.
18. Barbato A, Panizzolo C, Monciotti C, et al. Use of urokinase in
childhood pleural empyema. Pediatr Pulmonol 2003; 35: 50-5.
19. Stefanutti G, Ghirardo V, Barbato A, et al. Evaluation of a pediatric
protocol of intrapleural urokinase for pleural empyema: a
prospective study. Surgery 2010; 148: 589-94.
20. Tokuda Y, Matsushima D, Stein GH, et al. Intrapleural fibrinolytic
agents for empyema and complicated parapneumonic effusions: a
meta-analysis. Chest 2006; 129: 783-90.
21. Simpson G, Roomes D, Reeves B. Successful treatment of
empyema thoracis with human recombinant deoxyribonuclease.
Thorax 2003; 58: 365-6.
22. Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue
plasminogen activator and DNase in pleural infection. N Engl J Med
2011; 365: 518-26.
23. Paraskakis E, Vergadi E, Cathzimichael A, Bouros D. Current
evidence for the management of paediatric parapneumonic
effusions. Curr Med Res Opin 2012; 28: 1179-92.
24. Patradoon-Ho P, Fitzgerald DA. Lung abscesses in children. Paediatr
Respir Rev 2007; 8: 77-84.
Neumonía complicada en pediatría, su manejo: un reto - Agudelo B.
Neumol Pediatr 2013; 8 (2): 79-85.